Stay updated on Efruxifermin in NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Efruxifermin in NASH Cirrhosis Clinical Trial page.

Latest updates to the Efruxifermin in NASH Cirrhosis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new version of a study related to Efruxifermin, changing from revision v2.14.4 to v2.15.0, along with an updated date.SummaryDifference2%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 26, 2025. However, the removal of the date for March 25, 2025, does not significantly impact the core content.SummaryDifference1.0%
- Check66 days agoChange DetectedThe page has updated the study date for Efruxifermin in subjects with compensated cirrhosis due to NASH from April 25, 2023, to February 26, 2025.SummaryDifference1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Efruxifermin in NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Cirrhosis Clinical Trial page.